| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |